Kazia Therapeutics Limited KZIA

$ 6.59 19.38%

Annual report 2022
added 10-17-2022

Kazia Therapeutics Limited Income Statement 2011-2024 | KZIA

Annual Income Statement Kazia Therapeutics Limited

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	132 M	941 M	584 M	16 M	17.4 M	15.8 M	31.8 M	33.2 M	20.1 M	17.7 M	2.76 M	6.39 M
Shares	132 M	118 M	73.1 M	5.75 M	4.84 M	4.68 M	4.27 M	2.38 M	1.57 M	1.15 M	1.02 M	1.02 M
Historical Prices	1	8.42	8.64	4.34	2.43	3.18	5.88	8.36	8.32	17.2	9.15	2.63
Net Income	-24.6 M	-8.42 M	-12.5 M	-10.3 M	-6.04 M	-10.7 M	-12.1 M	-7.14 M	-7.47 M	-1.03 M	1.31 M	-6.5 M
Revenue	-	-	-	-	-	-	-	-	-	1.07 M	1.51 M	2.02 M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	89 K	87 K	1.11 M	1.51 M	2.02 M
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-7.74 M	-10.9 M	-8.93 M	-12.1 M	-7.57 M	-5.83 M	-1.7 M	-9.65 M	-11.4 M
Operating Expenses	-	-	-	8.82 M	12.5 M	10.4 M	12.8 M	8.14 M	6.4 M	3.11 M	11.2 M	13.5 M
General and Administrative Expenses	4.51 M	7.02 M	3.69 M	3.79 M	5.6 M	7.76 M	5.76 M	3.84 M	4.27 M	2.85 M	5.79 M	9.56 M

All numbers in AUD currency

Quarterly Income Statement Kazia Therapeutics Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in AUD currency